Head to head

Vbeam Prima vs Cynergy (2026)

Compare purchase costs, running costs and the evidence behind each device.

Read the comparison overview

Purchase cost: The catalog lists $120k–$160k for Vbeam Prima. No new-price range is on file for Cynergy. Check the source notes and request current quotes.
Practice fit: Both are listed under pulsed dye vascular. Check each model’s US regulatory status and labeled indications for your intended use.

Device A

Pulsed Dye Vascular

View full device profile →

Device B

Pulsed Dye Vascular

View full device profile →

Price comparison

Price comparison: Candela Vbeam Prima vs Cynosure Cynergy
Attribute	Candela Vbeam Prima	Cynosure Cynergy
New price range	$120k–$160kSource not documented	Not published
Used asking range	$60k–$95kSource not documented	$20k–$35kSource not documented
Payback calculator	View ROI calculator	View ROI calculator
Next step		Explore this model’s specs and owner reviews. For new-equipment inquiries, browse current models. Browse current models

New price range

Candela Vbeam Prima: $120k–$160kSource not documented
Cynosure Cynergy: Not published

Used asking range

Candela Vbeam Prima: $60k–$95kSource not documented
Cynosure Cynergy: $20k–$35kSource not documented

Payback calculator

Candela Vbeam Prima: View ROI calculator
Cynosure Cynergy: View ROI calculator

Next step

Candela Vbeam Prima

Cynosure Cynergy

Explore this model’s specs and owner reviews. For new-equipment inquiries, browse current models.

Browse current models

Consumable economics

Consumable economics: Candela Vbeam Prima vs Cynosure Cynergy
Attribute	Candela Vbeam Prima	Cynosure Cynergy
Consumable cost / lock-in	Supply pricing is not documented with a dated source yet. Request an itemized supply quote. — hard-lock — electronic lockout enforces single use	—
Service cost	Not published	Not published

Consumable cost / lock-in

Candela Vbeam Prima: Supply pricing is not documented with a dated source yet. Request an itemized supply quote. — hard-lock — electronic lockout enforces single use
Cynosure Cynergy: —

Service cost

Candela Vbeam Prima: Not published
Cynosure Cynergy: Not published

FDA clearance

FDA clearance: Candela Vbeam Prima vs Cynosure Cynergy
Attribute	Candela Vbeam Prima	Cynosure Cynergy
FDA status & indication	FDA ClearedK180593, K183452, K230990 Read FDA indication wording “1,064nm: The Vbeam Prima Laser System is intended for the coagulation and hemostasis of benign vascular lesions such as, but not limited to, port wine stains, hemangiomas, warts, telangiectasia, rosacea, venus lakes, leg veins, spider veins, and poikiloderma of civatte and treatment of benign cutaneous lesions such as, but not limited to lentigos (age spots), solar lentigos (sun spots), cafe au lait manules, seborrheic keratoses, nevi, chloasma, verrucea, skin tags, and keratoses. The laser is also indicated for the treatment of wrinkles such as, but not limited to, periocular and perioral wrinkles. 595 nm: General Surgery: Photocoagulation of benign cutaneous vascular lesions and benign cutaneous lesions. Dermatology/Plastic Surgery: For treatment of benign cutaneous vascular lesions, such as facial and leg telangiectasia, rosacea, port wine stains, hemangiomas, angioma, spider angioma, poikiloderma of civatte, and benign cutaneous lesions, such as warts, scars, striae, psoriasis and the treatment of wrinkles. Treatment of benign epidermal pigmented lesions. Treatment of inflammatory acne vulgaris. Gynecology: Photocoagulation of benign cutaneous lesions and benign vascular lesions in gynecology. Podiatry: Treatment of benign cutaneous lesions, such as warts.”	FDA ClearedK050779 Read FDA indication wording “585 - 600nm: The Cynergy laser is indicated for benign vascular and vascular dependant lesions removal. 1,064nm: The Cynergy laser is intended for the coagulation and hemostasis of benign vascular lesions such as, but not limited to, port wine stains, hemangiomas, warts, telangiectasia, rosacea, venus lakes, leg veins, spider veins, and poikiloderma of civatte and treatment of benign cutaneous lesions such as, but not limited to lentigos (age spots), solar lentigos (sun spots), caf6 au lait manules, seborrheic keratoses, nevi, chloasma, verrucea, skin tags, keratoses, tattoos (significant reduction in the intensity of black and/or blue/black tattoos) and plaques. The laser is also indicated for the treatment of wrinkles such as, but not limited to, periocular and perioral wrinkles. Additionally, the laser is intended for the removal of unwanted hair, for the stable long term, or permanent, hair reduction through selective targeting of melanin in hair follicles, and for the treatment of psuedofolliculitis barbae (PFB). 585 - 600nm with 1,064nm Wavelength Multiplex Mode: The wavelength multiplex mode is intended for benign vascular and vascular dependant lesions removal.”

FDA status & indication

Candela Vbeam Prima: FDA ClearedK180593, K183452, K230990
Read FDA indication wording
“1,064nm: The Vbeam Prima Laser System is intended for the coagulation and hemostasis of benign vascular lesions such as, but not limited to, port wine stains, hemangiomas, warts, telangiectasia, rosacea, venus lakes, leg veins, spider veins, and poikiloderma of civatte and treatment of benign cutaneous lesions such as, but not limited to lentigos (age spots), solar lentigos (sun spots), cafe au lait manules, seborrheic keratoses, nevi, chloasma, verrucea, skin tags, and keratoses. The laser is also indicated for the treatment of wrinkles such as, but not limited to, periocular and perioral wrinkles. 595 nm: General Surgery: Photocoagulation of benign cutaneous vascular lesions and benign cutaneous lesions. Dermatology/Plastic Surgery: For treatment of benign cutaneous vascular lesions, such as facial and leg telangiectasia, rosacea, port wine stains, hemangiomas, angioma, spider angioma, poikiloderma of civatte, and benign cutaneous lesions, such as warts, scars, striae, psoriasis and the treatment of wrinkles. Treatment of benign epidermal pigmented lesions. Treatment of inflammatory acne vulgaris. Gynecology: Photocoagulation of benign cutaneous lesions and benign vascular lesions in gynecology. Podiatry: Treatment of benign cutaneous lesions, such as warts.”
Cynosure Cynergy: FDA ClearedK050779
Read FDA indication wording
“585 - 600nm: The Cynergy laser is indicated for benign vascular and vascular dependant lesions removal. 1,064nm: The Cynergy laser is intended for the coagulation and hemostasis of benign vascular lesions such as, but not limited to, port wine stains, hemangiomas, warts, telangiectasia, rosacea, venus lakes, leg veins, spider veins, and poikiloderma of civatte and treatment of benign cutaneous lesions such as, but not limited to lentigos (age spots), solar lentigos (sun spots), caf6 au lait manules, seborrheic keratoses, nevi, chloasma, verrucea, skin tags, keratoses, tattoos (significant reduction in the intensity of black and/or blue/black tattoos) and plaques. The laser is also indicated for the treatment of wrinkles such as, but not limited to, periocular and perioral wrinkles. Additionally, the laser is intended for the removal of unwanted hair, for the stable long term, or permanent, hair reduction through selective targeting of melanin in hair follicles, and for the treatment of psuedofolliculitis barbae (PFB). 585 - 600nm with 1,064nm Wavelength Multiplex Mode: The wavelength multiplex mode is intended for benign vascular and vascular dependant lesions removal.”

Which chains run each

Which chains run each: Candela Vbeam Prima vs Cynosure Cynergy
Attribute	Candela Vbeam Prima	Cynosure Cynergy
Chain adoption	0 recorded pairings	0 recorded pairings
Chains using it	—	—
Approved reviews	0	0

Chain adoption

Candela Vbeam Prima: 0 recorded pairings
Cynosure Cynergy: 0 recorded pairings

Chains using it

Candela Vbeam Prima: —
Cynosure Cynergy: —

Approved reviews

Candela Vbeam Prima: 0
Cynosure Cynergy: 0

Specs and platform

Specs and platform: Candela Vbeam Prima vs Cynosure Cynergy
Attribute	Candela Vbeam Prima	Cynosure Cynergy
Manufacturer	Candela	Cynosure
Built by (OEM)	Candela Corporation	Cynosure LLC
Category	Pulsed Dye Vascular	Pulsed Dye Vascular
Technology	595nm PDL + 1064nm Nd:YAG (Nd:YAG)	585nm PDL + 1064nm Nd:YAG MultiPlex (Nd:YAG)
Launch year	2018	2006
Status	Current	Legacy-used-market
Manufacturer source record	No linked source on file.	No linked source on file.

Manufacturer

Candela Vbeam Prima: Candela
Cynosure Cynergy: Cynosure

Built by (OEM)

Candela Vbeam Prima: Candela Corporation
Cynosure Cynergy: Cynosure LLC

Current alternatives

Current catalog models in related categories. Confirm availability and configuration with the supplier.

Candela Vbeam Perfecta

Pulsed Dye Vascular

New: $90k–$110k

Get a free recommendation Browse by goal

Device and company names are trademarks of their respective owners. The Aesthetic Index is not affiliated with or endorsed by any manufacturer, distributor or lender named here, except as disclosed. Price figures are references, not current offers. Check each device’s source notes. Not medical, legal or regulatory advice.